Correlation Between Swiss Leader and Newron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Swiss Leader and Newron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiss Leader and Newron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiss Leader Price and Newron Pharmaceuticals SpA, you can compare the effects of market volatilities on Swiss Leader and Newron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiss Leader with a short position of Newron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiss Leader and Newron Pharmaceuticals.
Diversification Opportunities for Swiss Leader and Newron Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Swiss and Newron is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Swiss Leader Price and Newron Pharmaceuticals SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Newron Pharmaceuticals and Swiss Leader is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiss Leader Price are associated (or correlated) with Newron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Newron Pharmaceuticals has no effect on the direction of Swiss Leader i.e., Swiss Leader and Newron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Swiss Leader and Newron Pharmaceuticals
Assuming the 90 days trading horizon Swiss Leader Price is expected to under-perform the Newron Pharmaceuticals. But the index apears to be less risky and, when comparing its historical volatility, Swiss Leader Price is 5.77 times less risky than Newron Pharmaceuticals. The index trades about -0.12 of its potential returns per unit of risk. The Newron Pharmaceuticals SpA is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 775.00 in Newron Pharmaceuticals SpA on September 27, 2024 and sell it today you would earn a total of 74.00 from holding Newron Pharmaceuticals SpA or generate 9.55% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Swiss Leader Price vs. Newron Pharmaceuticals SpA
Performance |
Timeline |
Swiss Leader and Newron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Swiss Leader Price
Pair trading matchups for Swiss Leader
Newron Pharmaceuticals SpA
Pair trading matchups for Newron Pharmaceuticals
Pair Trading with Swiss Leader and Newron Pharmaceuticals
The main advantage of trading using opposite Swiss Leader and Newron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiss Leader position performs unexpectedly, Newron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Newron Pharmaceuticals will offset losses from the drop in Newron Pharmaceuticals' long position.Swiss Leader vs. BB Biotech AG | Swiss Leader vs. Basellandschaftliche Kantonalbank | Swiss Leader vs. St Galler Kantonalbank | Swiss Leader vs. Thurgauer Kantonalbank |
Newron Pharmaceuticals vs. Santhera Pharmaceuticals Holding | Newron Pharmaceuticals vs. Basilea Pharmaceutica AG | Newron Pharmaceuticals vs. Addex Therapeutics | Newron Pharmaceuticals vs. Evolva Holding SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |